The stranded babies of Kyiv and the women who give birth for money
By Oksana Grytsenko,
The Guardian
| 06. 15. 2020
Lockdown exposed the scale of the commercial baby business in Ukraine, and now women hired for their wombs are speaking out, as part of this deep investigation.
Some are crying in their cots; others are being cradled or bottle-fed by nannies. These newborns are not in the nursery of a maternity hospital, they are lined up side by side in two large reception rooms of the improbably named Hotel Venice on the outskirts of Kyiv, protected by outer walls and barbed wire.
They are the children of foreign couples born to Ukrainian surrogate mothers at the Kyiv-based BioTexCom Centre for Human Reproduction, the largest surrogacy clinic in the world. They’re stranded in the hotel because their biological parents have not been able to travel in or out of Ukraine since borders closed in March because of the Covid-19 pandemic.
Anxious parents check on the children they have not yet met via video calls, and others have sent audio recordings of their voices to soothe the children
BioTexCom released video footage from the hotel in mid-May to highlight the heartbreaking dilemma for parents and to lobby for an easing of border closures.
The babies’ plight made headlines around the world, but a month on, some 50 babies remain in...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...